These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32380217)

  • 41. Telemedicine During the COVID-19 Crisis and Beyond.
    Blevins T; Ozer K
    Tex Med; 2020 Jul; 116(7):4-5. PubMed ID: 32872703
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Integration of telemedicine into the public health response to COVID-19 must include dentists.
    Maret D; Peters OA; Vaysse F; Vigarios E
    Int Endod J; 2020 Jun; 53(6):880-881. PubMed ID: 32320488
    [No Abstract]   [Full Text] [Related]  

  • 43. [Telemedicine at the heart of management of the COVID-19 crisis].
    Mazouri-Karker S; Percheron Vendeuvre L; Sandoval J; Regard S; Braillard O; Guessous I; Nehme M
    Rev Med Suisse; 2020 Sep; 16(706):1699-1702. PubMed ID: 32936553
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reply to Fenton
    Bruni T; Lalvani A; Richeldi L
    Am J Respir Crit Care Med; 2020 Oct; 202(8):1192-1193. PubMed ID: 32790518
    [No Abstract]   [Full Text] [Related]  

  • 45. COVID-19 and its implications for Dermatology and Venereology.
    Ring J
    J Eur Acad Dermatol Venereol; 2020 May; 34(5):914. PubMed ID: 32441430
    [No Abstract]   [Full Text] [Related]  

  • 46. [Not Available].
    Al Joboory S; Monello F; Soulan X; Fernândez VA; Bouchard JP
    Rev Infirm; 2020; 69(263):37-39. PubMed ID: 32993905
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An Expanded COVID-19 Telemedicine Intermediate Care Model Using Repurposed Hotel Rooms.
    Fenton ME; Wasko K; Behl V; Froh J; Schmalenberg M
    Am J Respir Crit Care Med; 2020 Oct; 202(8):1190-1192. PubMed ID: 32790480
    [No Abstract]   [Full Text] [Related]  

  • 48. COVID-19 and immunomodulator/immunosuppressant use in dermatology.
    Price KN; Frew JW; Hsiao JL; Shi VY
    J Am Acad Dermatol; 2020 May; 82(5):e173-e175. PubMed ID: 32224277
    [No Abstract]   [Full Text] [Related]  

  • 49. Ethical outpatient dermatology care during the coronavirus (COVID-19) pandemic.
    Pathoulas JT; Stoff BK; Lee KC; Farah RS
    J Am Acad Dermatol; 2020 May; 82(5):1272-1273. PubMed ID: 32224276
    [No Abstract]   [Full Text] [Related]  

  • 50. Big data and cutaneous manifestations of COVID-19.
    Grant-Kels JM; Sloan B; Kantor J; Elston DM
    J Am Acad Dermatol; 2020 Aug; 83(2):365-366. PubMed ID: 32305440
    [No Abstract]   [Full Text] [Related]  

  • 51. Creating dermatology guidelines for COVID-19: The pitfalls of applying evidence-based medicine to an emerging infectious disease.
    Freeman EE; McMahon DE
    J Am Acad Dermatol; 2020 Jun; 82(6):e231-e232. PubMed ID: 32278795
    [No Abstract]   [Full Text] [Related]  

  • 52. Teledermatology in the era of COVID-19: Experience of an academic department of dermatology.
    Perkins S; Cohen JM; Nelson CA; Bunick CG
    J Am Acad Dermatol; 2020 Jul; 83(1):e43-e44. PubMed ID: 32305442
    [No Abstract]   [Full Text] [Related]  

  • 53. The coronavirus (COVID-19) epidemic and patient safety.
    Elston DM
    J Am Acad Dermatol; 2020 Apr; 82(4):819-820. PubMed ID: 32074487
    [No Abstract]   [Full Text] [Related]  

  • 54. What does it mean to be made vulnerable in the era of COVID-19?
    Ahmad A; Chung R; Eckenwiler L; Ganguli-Mitra A; Hunt M; Richards R; Saghai Y; Schwartz L; Scully JL; Wild V
    Lancet; 2020 May; 395(10235):1481-1482. PubMed ID: 32353327
    [No Abstract]   [Full Text] [Related]  

  • 55. Store-and-forward teledermatology in the era of COVID-19: A pilot study.
    Cartron AM; Rismiller K; Trinidad JCL
    Dermatol Ther; 2020 Jul; 33(4):e13689. PubMed ID: 32458535
    [No Abstract]   [Full Text] [Related]  

  • 56. Dermatology patients' knowledge and concerns regarding their immunomodulatory medication during the COVID-19 pandemic.
    Keeling E; Daly S; McKenna DB
    Dermatol Ther; 2020 Jul; 33(4):e13488. PubMed ID: 32356601
    [No Abstract]   [Full Text] [Related]  

  • 57. Dermatology practices as vectors for COVID-19 transmission: A call for immediate cessation of nonemergent dermatology visits.
    Kwatra SG; Sweren RJ; Grossberg AL
    J Am Acad Dermatol; 2020 May; 82(5):e179-e180. PubMed ID: 32213307
    [No Abstract]   [Full Text] [Related]  

  • 58. Redefining vulnerability in the era of COVID-19.
    The Lancet
    Lancet; 2020 Apr; 395(10230):1089. PubMed ID: 32247378
    [No Abstract]   [Full Text] [Related]  

  • 59. COVID-19 can present with a rash and be mistaken for dengue.
    Joob B; Wiwanitkit V
    J Am Acad Dermatol; 2020 May; 82(5):e177. PubMed ID: 32213305
    [No Abstract]   [Full Text] [Related]  

  • 60. The COVID-19 response for vulnerable people in places affected by conflict and humanitarian crises.
    Nott D
    Lancet; 2020 May; 395(10236):1532-1533. PubMed ID: 32380045
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.